Contract Service Directory
Toxikon
Company Headquarters
15 Wiggins Ave
Bedford, MA 01730
United States
Company Description
Toxikon is a leading preclinical contract research organization (CRO) providing in vivo, in vitro, and analytical testing services for the medical device, biotechnology, and pharmaceutical industries - helping those companies gain approval for their products quickly and bring them to market successfully.
Contract Service Directory
- Accelerated Stability Studies
- ADMET
- Analytical Laboratory Services
- Analytical Methods Development
- Analytical Validation Studies
- Assay Development
- Bioanalytical Analysis LC/MS/MS
- Bioanalytical Services
- Biological Testing
- Cell Culture Media Development
- Chemical Analysis
- Chromatographic Analysis, LC/GC
- Container Testing
- Contract Research
- Custom Protocols
- Drug Development Services
- Drug Discovery Support Services
- Efficacy Testing
- Extractables / Leachables Testing
- Formulation Development
- Formulation Services
- HPLC
- Immunobiology Services
- Immunotoxicity Testing
- In Vitro Testing
- In Vivo Testing
- IND/NDA Submissions
- Mass Spectrometry
- Materials Analysis
- Metabolic Analysis
- Methods Development
- Methods Validation
- Microbiological Testing
- Pharmacokinetics
- Pharmacology
- Photostability
- Preclinical Study Design
- Preclinical Testing
- Preclinical Testing Formulations
- QA/QC
- R&D Services
- Radiopharmaceuticals
- Raw Materials Analysis
- Stability Studies
- Stability, ICH
- Sterility Testing
- Toxicology Services & Analysis
- Trace Metal Analysis, ICP
- UV-VIS Spectrophotometer Analysis
- Wet Chemical Analysis
Contract Services Directory
Related Content
-
Clinical Trials | CRO News | Laboratory Testing | Toxicology
Navigating a Competitive CRO Landscape
Jacob McDonald of Lovelace Biomedical looks at consolidation in an increasingly competitive environmentJake McDonald, Ph.D., Chief Scientific Officer, Lovelace Biomedical 11.15.19
-
Analytical Services | Industry News | Laboratory Testing
Sterigenics Acquires Toxikon’s European Lab Biz
Acquisition creates leading extractables and leachables lab testing platform11.02.17
-
Breaking News | Drug Discovery | Validation
Toxikon, Ocean Ridge Biosciences In Services Partnership
To globally market respective discovery/development expertise10.27.11
-
Breaking News | Chemistry | CRO News | Industry News | Laboratory Testing | Preclinical Outsourcing
Toxikon Expands ESRS
Preclinical CRO begins construction on expanded Efficacy and Ssurgical Research Services wingGil Roth 06.27.11
-
Breaking News | Promotions & Moves
BASi
BASi (Bioanalytical Systems Inc.) has added three representatives to its business development team.12.03.10
-
Breaking News | Drug Discovery | Industry News | Toxicology
Toxikon Completes Tox Studies for Cellceutix
Toxikon Corp. has completed toxicity studies in two species for Cellceutix Corp.’s Kevetrin, a compound in development for the treatment of resistant lung and breast cancers.11.03.10
-
Breaking News | Industry News | Toxicology
Toxikon Adds Cancer Assay
Toxikon has added the Comet Assay IV Analysis System developed by Perceptive Instruments to its genetic and molecular toxicology study offerings.09.02.10
-
Breaking News | Industry News | Toxicology
Toxikon Expands Immunotoxicology Services
Toxikon Corp. has expanded its immunotoxicology offerings, adding flow cyctometry, which enables the direct analysis of cells to detect a variety of specifically labeled components.09.22.09
